Alcon | Betoptic (Medication)
Betoptic has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of patients with chronic open-angle glaucoma; patients with elevated intraocular pressure (ocular hypertensive patients). It may be used alone or in combination with other intraocular pressure lowering medications. Betoptic ophthalmic contains betaxolol hydrochloride, a cardioselective beta-adrenergic receptor inhibitor, in a sterile resin suspension formulation.
Instill one drop of Instill one drop of Betoptic (betaxolol hydrochloride ophthalmic suspension) Ophthalmic Suspension 0. 25% in the affected eye twice daily. ...
Most common side effects may include:blurred vision, corneal punctate keratitis, foreign body sensation, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, ocular pain, decreased visual acuity and crusty lashes.
Additional medical events reported with other formulations of betaxolol include allergic reactions, decreased corneal sensitivity, corneal punctate staining which may appear in dendritic formations, edema and anisocoria. ...
Like any other beta-adrenergic receptor inhibitors, Betoptic should be administered with caution in patients subject to hypoglycemia or to diabetic patients (especially those with labile diabetes) who are receiving insulin or oral hypoglycemic agents. As with many topically applied ophthalmic drugs, this drug is absorbed systemically. The same adverse reactions found with systemic administration of beta- adrenergic receptor inhibitors may occur with topical administration.
During pregnancy and breastfeeding is not recommended to use this medicine without your doctor's advice. ...